Lifeboat Foundation

Why do some people love Impressionist paintings like Claude Monet’s “Water Lilies” (1906) while others can’t understand the hype? The question of aesthetic taste has stumped scholars for centuries. Now, neuroscientists at the California Institute of Technology (CalTech) say they have come closer to decoding how the brain decides which artworks it deems good or attractive.

In a study published in the scientific journal Nature Communications, CalTech Professor John O’Doherty and other researchers propose that the mind creates an opinion of an artwork after dissecting it into discrete elements. Basic features, such as color and texture, and complex qualities, like style, are ranked and weighed individually to make a judgment.

Connect with top gaming leaders in Los Angeles at GamesBeat Summit 2023 this May 22–23. Register here.

While AI has been a part of game development for years, generative AI’s ability to create assets for games instantly is a relatively new component. This new technology has the capacity to serve as a tool for game developers, especially those with smaller teams — and, according to the creators of Story Machine, it already is.

Continue reading “Story Machine demonstrates how AI is helping game development” »

Astronomers interpret the spectra of 10 well-known dark asteroids and find them to be water-rich like the dwarf planet Ceres.

Thank You For Watching.

Please Like And Subscribe to Our Channel: https://www.youtube.com/EasyPeasyLearning.

Continue reading “Glycogenolysis: This Video Explains The Process Of Glycogenolysis” »

Do you use the “tap” function on your debit card at ATMs? There’s now a new kind of scam — here’s how to avoid it:

Artificial Intelligence (AI) is unarguably the most exciting field in robotics. And humanoid robots, robots resembling the human body in shape, are one of the most popular forms of AI. However, a lot of work, finances, and research are put into making these humanoid robots.

The field is already crowded with a number of companies with interesting projects, such as Boston Dynamics’ Atlas robot and Tesla’s much-hyped Optimus prototype designed to be “general purpose.”

This week, an AI Robotics startup, Figure, has unveiled Figure 1, the world’s first commercially viable general-purpose humanoid robot. The company says this humanoid will have the ability to think, learn, and interact with its environment.

“People on metformin have 30% lower rates of almost every kind of cancer. It delays cognitive decline. Even people with diabetes who are obese and have more disease to start with but are on metformin have lower mortality rates than people without diabetes who aren’t on the drug.”

What he says is born out in numerous studies. Overall, this safe, super-cheap, decades-old drug not only treats diabetes, but it also seems to delay and compress the years of chronic illness associated with the final stage of life and extend what geroscientists call the “healthspan.”

Metformin is just one of many medications, including other old ones and some brand new inventions, that academic researchers and biotech startups are exploring to slow, stop, or perhaps even reverse aging.

► Twitter: https://twitter.com/weirdworldtv.
► Subscribe to Weird World: http://bit.ly/WeirdWorldSub.

NEW VIDEOS EVERY FRIDAY & SATURDAY!

Continue reading “3 Signs The UNIVERSE IS ACTUALLY A GIANT BRAIN” »

Researchers hope KRAS test can serve renewed function as soon as possible Scientists have found an existing gene test frequently used on the NHS can also shed light on whether a bowel cancer patient will respond positively or negatively to chemotherapy. Researchers from The Institute of Cancer Research, Imperial College London and the Netherlands Cancer Institute have found the KRAS test can have use beyond its current function of predicting how patients will react to cancer drug cetuximab.